Adamas Pharmaceuticals
ADMS
#7168
Rank
NZ$0.66 B
Marketcap
$14.44
Share price
0.00%
Change (1 day)
17,266.62%
Change (1 year)

Earnings for Adamas Pharmaceuticals (ADMS)

Earnings in 2021 (TTM): -NZ$54.73 Million

According to Adamas Pharmaceuticals 's latest financial reports the company's current earnings are NZ$88.18 Million. In 2020 the company made an earning of -NZ$77.05 Million, an increase over its 2019 earnings that were of -NZ$0.16 Billion.

Earnings history for Adamas Pharmaceuticals from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-NZ$54.73 Million-28.96%
2020-NZ$77.05 Million-51.34%
2019-NZ$0.16 Billion-19.45%
2018-NZ$0.2 Billion28.96%
2017-NZ$0.16 Billion42.3%
2016-NZ$0.11 Billion6.18%
2015-NZ$0.11 Billion-410.24%
2014NZ$32.51 M-67.53%
2013NZ$0.10 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.38 Billion 448.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.17 B-353.36%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.52 B-9,719.72%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.71 B-11,476.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$37.24 B-54,999.17%๐Ÿ‡บ๐Ÿ‡ธ USA